The city of Colorado Springs, Colorado, currently has 2 active clinical trials seeking participants for COVID19 research studies.
A Study to Evaluate VXA-CoV2-3.1 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection
Recruiting
The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/01/2024
Locations: Elite Research Network (ERN) - Legacy Clinical Trials, Colorado Springs, Colorado
Conditions: SARS-CoV2, COVID-19
ASYMPTOMATIC AND PRE-SYMPTOMATIC TRANSMISSION OF SARS-COV-2 IN A COMMUNITY CONGREGANT SETTING
Recruiting
The overall aim of this study is to measure how transmission of COVID-19 occurs in communities - including the role of super spreaders and/or identifying conditions that may increase transmission risk, with a focus on congregant situations. In order to identify how presence of symptoms and behavior affects the transmissibility of the virus, we will measure SARS-CoV-2 in exhaled breath of asymptomatic and symptomatic persons using polyvinyl alcohol (PVA) test strips embedded in face masks (Face M... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/01/2021
Locations: University of Colorado, Colorado Springs, Colorado Springs, Colorado
Conditions: COVID-19, SARS-CoV2 Infection